Ardelyx, Inc. (ARDX) vs Verastem, Inc. (VSTM)
- Ardelyx, Inc. ARDX 3.09 −5.50%
- Verastem, Inc. VSTM 8.65 −6.28%
Ardelyx, Inc. and Verastem, Inc. are both Biotechnology companies. Ardelyx, Inc. and Verastem, Inc. are of similar size ($835.9M and $814.9M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against 16.8%. Ardelyx, Inc. has the higher net margin (−12.4% vs −231.6%) and the lower return on invested capital (−18.6% vs 0.00%). Across the 18 metrics below, Ardelyx, Inc. leads on 13 and Verastem, Inc. on 5.
Valuation
Profitability
| Metric | ARDX | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 86.35% | 65.16% |
| Operating margin | (7.86%) | (182.57%) | 0.00% |
| Net margin | (12.35%) | (231.59%) | 0.00% |
| Free cash flow margin | (3.97%) | (185.31%) | 0.00% |
| Return on equity | (38.61%) | (471.16%) | (56.36%) |
| Return on assets | (10.68%) | (100.65%) | (48.04%) |
| Return on invested capital | (18.62%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack